Find Articles



Return to:Adhd Articles
Or:Recent Adhd Articles

LIALDA demonstrates prolonged release of mesalamine in an in vitro ...


http://www.eurekalert.org/pub_releases/2007-10/sp-ldp1017...

EurekAlert - Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the ...



Article Finder:

October 17, 2007 09:23:00 AM
Article Directory